Don’t Miss these ExpertED@SSO Educational Activities

Share on facebook
Share on twitter
Share on linkedin

experted-logoIf it’s been a while since you visited SSO’s learning management system, ExpertED@SSO, it’s time to take another look. ExpertED has recently been updated to give you better access to premier educational programs developed by leaders in the field.  Below are some of the most recent webinars and Annals of Surgical Oncology CME articles.

Breast Conserving Surgery: New Issues and Outcomes in an Old Procedure

Faculty: Monica Morrow, MD, Tari King, MD and Kimberly Van Zee, MD

This webinar reviews new patient outcome data regarding invasive cancer and margins as it relates to breast conserving surgery after neoadjuvant chemotherapy, imaging evaluation, extent of resection and local regional recurrence outcomes. This newer data will be placed in context of previously published guidelines, the controversies that exist regarding optimal margins and clinical practice implications in the era of multidisciplinary therapy. You may find this archived webinar in the Breast Disease section of the ExpertED@SSO catalog.

Insights and Updates in the Multidisciplinary Treatment of Metastatic Melanoma

Faculty: Jonathan Zager, MD and Nikhil Khushalani, MD

Clinical trial data are lacking on the role of surgery in the multidisciplinary treatment of metastatic melanoma. With the absence of surgery specific data, surgeons need access to expert guidance and real-world evidence to guide decision making. With the availability of a newly approved intralesional therapy for in-transit and unresectable melanoma, surgeons need to understand when to recommend this treatment and the associated adverse event profiles. You may find this archived webinar in the Melanoma Disease section of the ExpertED@SSO catalog.

Annals of Surgical Oncology Journal MOC

Survival in Patients with High-Grade Colorectal Neuroendocrine Carcinomas: The Role of Surgery and Chemotherapy

Authors: Adam C. Fields, Pamela Lu, Benjamin M. Vierra, Frances Hu, Jennifer Irani, Ronald Bleday, Joel E. Goldberg, Garrett M. Nash, and Nelya Melnitchouk

Colorectal neuroendocrine tumors are a rare malignancy, yet their incidence appears to be increasing. The optimal treatment for the high-grade subset of these tumors remains unclear.  This publication examines the relationship between different treatment modalities and outcomes for patients with high-grade neuroendocrine carcinomas (HGNECs) of the colon and rectum.

Annals of Surgical Oncology Journal MOC

Correlates of Refusal of Surgery in the Treatment of Nonmetastatic Pancreatic Adenocarcinoma

Authors: Alex Coffman, MD, Anna Torgeson, MD and Shane Lloyd, MD

Surgical resection is the most important therapeutic intervention for eligible patients with pancreatic cancer; however, a majority of patients never receive surgery for a variety of reasons, including patient refusal. Utilizing the National Cancer Database, the authors investigated the associated sociodemographic and clinical factors for those patients who refused surgery, and the impact of this decision on overall survival.

Annals of Surgical Oncology Journal MOC

Surgical Management of Primary Retroperitoneal Sarcomas: Rationale for Selective Organ Resection

Authors: Mark Fairweather, MD, Jiping Wang, MD, PhD, Vickie Y. Jo, MD, Elizabeth H. Baldini, MD, MPH, Monica M. Bertagnolli, MD, and Chandrajit P. Raut, MD, MSc

Recently, some have argued for routine resection of adjacent but uninvolved organs in patients with retroperitoneal sarcoma (RPS) without stipulating the rationale for such organ resection (beyond the need to achieve a macroscopically complete resection) or examining histopathologic organ invasion (HOI). This study reviewed the authors’ experience with primary RPS to investigate the rate and rationale for individual organ resection and the rate of HOI.

Scroll to Top